Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03521518 · ClinicalTrials.gov registry record

CPT-3 in Normal Pressure Hydrocephalus

A clinical trial, sponsored by Vanderbilt University Medical Center.

Terminated
Registry status
8
Enrollment target

NCT03521518 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03521518 was terminated before completion, sponsored by Vanderbilt University Medical Center.

TERMINATED
Registry status
8 participants
Enrollment target

Study Summary

The study will collect prospective cohort data of individuals that are undergoing routine clinical care for suspected idiopathic Normal Pressure Hydrocephalus (NPH). The administration of the Conner's Continual Performance Test - version 3 (CPT-3), an automated 14-minute computerized measure of reaction-time and sustained attention, will be added to the current neurocognitive screen being used (i.e., the Montreal Cognitive Assessment, MoCA) along with gait assessment. Patients will undergo pre-tap testing on the morning of their large volume Lumbar Puncture (CSF-TT). These patients will receive post-tap CPT-3 and MoCA testing one-to-three hours post-tap, and again at 2-3 days post-CSF-TT, during the follow-up appointment in clinic. The standard NPH quantitative assessment methods of MoCA and gait evaluation will continue to be collected. For those patients that ultimately undergo ventricular shunt placement, the CPT-3 will be administered at their post-operative follow-up appointment (\~3 months post-operation). The results of CPT-3 will not factor into consideration for shunt candidacy.

Interventions

  • DIAGNOSTIC_TEST Conner's Continuous Performance Test-3

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2019-01-16
Est. Completion 2023-06-01

What the Registry Record Tells You About NCT03521518

The ClinicalTrials.gov registry entry for NCT03521518 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Conner's Continuous Performance Test-3 is the first listed.

NCT03521518 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03521518 about?

NCT03521518 is a clinical study titled "CPT-3 in Normal Pressure Hydrocephalus". The study will collect prospective cohort data of individuals that are undergoing routine clinical care for suspected idiopathic Normal Pressure Hydrocephalus (NPH). The administration of the Conner's Continual Performance Test - version 3 (CPT-3), an automated 14-minute computerized measure of reac...

What is the current status of trial NCT03521518?

This trial is currently terminated. The enrollment target is 8 participants. The study started on 2019-01-16. Estimated completion is 2023-06-01.

What interventions are being tested in trial NCT03521518?

The interventions under investigation include: Conner's Continuous Performance Test-3 (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03521518?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.